| Price | $25.79 |
| Year Range | $21.81 – $31.05 |
| Market Cap | $1.85B |
| Industry | Biotechnology |
What Is Zymeworks’s AI Stock Analysis?
Zymeworks’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks Zymeworks’s momentum in near-real time.
Zymeworks (ZYME) has an AltIndex AI Score of 39/100, currently a Sell signal. The AI Score distills Zymeworks's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.
Zymeworks’s Full AI Analysis
Keep reading AltIndex’s full AI analysis of Zymeworks — the fundamental, technical and alternative-data breakdown and the recommendation.
Sign up to read the full analysisWhat’s Driving ZYME’s AI Score?
Fundamentals
Revenue for the last quarter was $4.6M. This is an increase of 90.61% compared to the quarter before it, which is a positive sign of growth. However, compared to the same quarter last year, there is a decrease of 90.58%, which may be a cause for concern. Net income for the last quarter was $-45M. This represents a decrease of 1.94% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 2,042.99%, which may be a cause for concern. Ebitda for the last quarter was $-43M. This represents a decrease of 3.81% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 1,760.36%, which may be a cause for concern.
See Zymeworks’s earnings and insider transactions.
Technicals
Today's stock price is $25.79. This represents a decrease of 1.71% compared to a month ago, which may be concerning in the short-term. Compared to a year ago, there is an increase of 42.80%, suggesting a positive long-term trend. The trend is bearish. The current SMA10 is $25.66, which is lower than the previous SMA10 of $25.73. This suggests a potential downward trend in price movement. The RSI is 42.4, indicating a neutral condition.
See the full technical analysis and price prediction.
Alternative data
Zymeworks has an estimated 4 open positions. This number is down by -33% in the last couple of months, indicating a company trying to improve its margins or cut costs. Not a great sign for a growing company. The business outlook among employees at Zymeworks is neutral. Zymeworks has an estimate of 26,000 visitors to their webpage. The number of visitors is up by 100% in the last couple of months, a bullish trend as this can indicate can increase in customers.
Explore Zymeworks’s job postings, web traffic and app downloads.
Sentiment & social
However, the sentiment is down by -12% in the last couple of weeks, a worrisome trend. Zymeworks has 1,400 followers on their Twitter page, with no meaningful increase or decrese in the last couple of months.
Track Zymeworks’s market sentiment.
Frequently Asked Questions: Zymeworks AI Stock Analysis
Zymeworks's AltIndex AI Score is 39/100, currently a Sell signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.
AltIndex's AI Score model rates Zymeworks a Sell (39/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.
The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.
AltIndex generates a complete written AI analysis of Zymeworks — company overview, fundamentals, technicals and alternative data, with a recommendation. See the ZYME AI Score or sign up to read the full thesis.
